New key publication about drug development landscape for cancer bone metastasis

Founders of OncoBone Ventures participated in writing a newly published invited review article for the Journal Frontiers in Immunology. The publication titled ‘Insights into immuno-oncology drug development landscape with focus on bone metastasis’ provides a comprehensive review of the competitive drug development landscape for bone metastasis.

The full publication can be found from the following link: Kähkönen et al., Frontiers in Immunology, Vol 14, 2023.

Tiina Kähkönen, CSO of OncoBone Ventures and the lead author of the publication says: ‘It was a great pleasure to be invited to contribute a publication in Frontiers in Immunology. By using a sophisticated drug development database we were able to provide for the first time a comprehensive analysis of the drug development landscape for bone metastasis. This information is very important not only for OncoBone Ventures, but also globally for researchers working in the bone metastasis field.’